(2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine

C64H68F6N12O5 — CID 157149494

IUPAC(2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine
SMILESC[C@@H](O)C(=O)O.Cc1c(C2CCN(C(=O)[C@@H](C)O)CC2)nnc(-c2cccc(C(F)(F)F)c2)c1-c1ccnc(NC(C)c2ccccc2)n1.Cc1c(C2CCNCC2)nnc(-c2cccc(C(F)(F)F)c2)c1-c1ccnc(NC(C)c2ccccc2)n1
InChIInChI=1S/C32H33F3N6O2.C29H29F3N6.C3H6O3/c1-19-27(26-12-15-36-31(38-26)37-20(2)22-8-5-4-6-9-22)29(24-10-7-11-25(18-24)32(33,34)35)40-39-28(19)23-13-16-41(17-14-23)30(43)21(3)42;1-18-25(24-13-16-34-28(36-24)35-19(2)20-7-4-3-5-8-20)27(22-9-6-10-23(17-22)29(30,31)32)38-37-26(18)21-11-14-33-15-12-21;1-2(4)3(5)6/h4-12,15,18,20-21,23,42H,13-14,16-17H2,1-3H3,(H,36,37,38);3-10,13,16-17,19,21,33H,11-12,14-15H2,1-2H3,(H,34,35,36);2,4H,1H3,(H,5,6)/t20?,21-;;2-/m1.1/s1
InChIKeyALCAIJLXXKFMCC-WHBKXUGWSA-N
MW1199.31 g/mol
LogP12.21
Rot. Bonds14

About (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine

(2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine (PubChem CID 157149494) has the molecular formula C64H68F6N12O5 and a molecular weight of 1199.31 g/mol. Its IUPAC name is (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine.

Molecular Properties

Compound Name(2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine
PubChem CID157149494
Molecular FormulaC64H68F6N12O5
Molecular Weight1199.31 g/mol
Exact Mass1198.53
IUPAC Name(2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine
SMILESC[C@@H](O)C(=O)O.Cc1c(C2CCN(C(=O)[C@@H](C)O)CC2)nnc(-c2cccc(C(F)(F)F)c2)c1-c1ccnc(NC(C)c2ccccc2)n1.Cc1c(C2CCNCC2)nnc(-c2cccc(C(F)(F)F)c2)c1-c1ccnc(NC(C)c2ccccc2)n1
InChIInChI=1S/C32H33F3N6O2.C29H29F3N6.C3H6O3/c1-19-27(26-12-15-36-31(38-26)37-20(2)22-8-5-4-6-9-22)29(24-10-7-11-25(18-24)32(33,34)35)40-39-28(19)23-13-16-41(17-14-23)30(43)21(3)42;1-18-25(24-13-16-34-28(36-24)35-19(2)20-7-4-3-5-8-20)27(22-9-6-10-23(17-22)29(30,31)32)38-37-26(18)21-11-14-33-15-12-21;1-2(4)3(5)6/h4-12,15,18,20-21,23,42H,13-14,16-17H2,1-3H3,(H,36,37,38);3-10,13,16-17,19,21,33H,11-12,14-15H2,1-2H3,(H,34,35,36);2,4H,1H3,(H,5,6)/t20?,21-;;2-/m1.1/s1
InChIKeyALCAIJLXXKFMCC-WHBKXUGWSA-N
XLogP12.21
TPSA237.28 Ų
H-Bond Donors6
H-Bond Acceptors15
Rotatable Bonds14
Heavy Atoms87
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001199.31
LogP ≤ 512.21
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1015

Analyze (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine?
The IUPAC name of (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine (CID 157149494) is (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine.
What is the SMILES notation for (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine?
The canonical SMILES for (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine is C[C@@H](O)C(=O)O.Cc1c(C2CCN(C(=O)[C@@H](C)O)CC2)nnc(-c2cccc(C(F)(F)F)c2)c1-c1ccnc(NC(C)c2ccccc2)n1.Cc1c(C2CCNCC2)nnc(-c2cccc(C(F)(F)F)c2)c1-c1ccnc(NC(C)c2ccccc2)n1.
What is the InChIKey of (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine?
The InChIKey is ALCAIJLXXKFMCC-WHBKXUGWSA-N. The full InChI is InChI=1S/C32H33F3N6O2.C29H29F3N6.C3H6O3/c1-19-27(26-12-15-36-31(38-26)37-20(2)22-8-5-4-6-9-22)29(24-10-7-11-25(18-24)32(33,34)35)40-39-28(19)23-13-16-41(17-14-23)30(43)21(3)42;1-18-25(24-13-16-34-28(36-24)35-19(2)20-7-4-3-5-8-20)27(22-9-6-10-23(17-22)29(30,31)32)38-37-26(18)21-11-14-33-15-12-21;1-2(4)3(5)6/h4-12,15,18,20-21,23,42H,13-14,16-17H2,1-3H3,(H,36,37,38);3-10,13,16-17,19,21,33H,11-12,14-15H2,1-2H3,(H,34,35,36);2,4H,1H3,(H,5,6)/t20?,21-;;2-/m1.1/s1.
What are the key properties of (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine?
(2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine has a molecular weight of 1199.31 g/mol, XLogP of 12.21, 14 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-hydroxy-1-[4-[4-methyl-5-[2-(1-phenylethylamino)pyrimidin-4-yl]-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]piperidin-1-yl]propan-1-one;(2R)-2-hydroxypropanoic acid;4-[5-methyl-6-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-(1-phenylethyl)pyrimidin-2-amine is sourced from PubChem (CID 157149494), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).